A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high‐risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group
Adam J. Esbenshade; Mehmet Kocak; Linda Hershon; Pierre Rousseau; Jean‐Claude Decarie; Susan Shaw; Peter Burger; Henry S. Friedman; Amar Gajjar; Albert Moghrabi
Author Information: Monroe Carrell Jr. Children's Hospital at Vanderbilt, Vanderbilt Ingram Cancer Center
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.